Edema tardio intermitente e persistente - etip: reação adversa após infiltração com ácido hialurônico

Reinaldo Antônio  Alves Júnior; Adriano Linares; Diógenes Rodrigues Lima; Thyago Almeida de Oliveira; Alessandro Queiroz de Mesquita

Authors

Reinaldo Antônio Alves Júnior Autor
Adriano Linares Autor
Diógenes Rodrigues Lima Autor
Thyago Almeida de Oliveira Autor
Alessandro Queiroz de Mesquita Autor

Keywords:

Hyaluronic acid, TEIP, corticosteroid

Abstract

Hyaluronic acid (HA), also known as hyaluronate, is a high molecular weight polysaccharide, disseminated through intra-articular injections used as a form of viscosupplementation for the treatment of osteoarthritis, but recently, there has been growing interest in the use of this substance for the treatment of osteoarthritis. treatment of soft tissue pathologies such as tendinopathies, ankle sprains, epicondylitis, subacromial bursitis and partial rotator cuff tears. In this specific case, HA was used for the treatment of medial epicondylitis, having as an adverse effect a Late Intermittent and Persistent Edema - TEIP. The treatment of this side effect was performed aiming at improving the clinical picture induced by HA, using celocoxib 200mg, analgesic, prednisone 40mg and cryotherapy.

References

Laurent TC, Fraser JR. Hyaluronan. FASEB J, v. 6, n. 7, p. 2397-404, 1992.

Meyer K, Palmer JW. The polysaccharide of vitreous humor. J Biol Chem. 1934; 107:629-34

Roque V, Agre M, Barroso J, Brito I. Managing knee ostheoarthritis: efficacy of hyaluronic acid injections. Acta Reumatol Port. 2013; 38:154-61.

Campbell RS, Dunn AJ. Radiological interventions for soft tissue injuries in sport. Br J Radiol. 2012 aug;85(1016):1186-93.

Cavallieri FA. Edema tardio intermitente e persistente etip: reação adversa tardia ao preenchedor de ácido hialurônico. Surg Cosmet Dermatol. 2017;9(3):218-22.

Artzi O, Lozides C, Verner I, Landau M. Resistant and recurrent late reaction to hyaluronic acid-based gel. Dermatol Surg. 2016;42(1):31-7.

Vargas A, Amorim N, Pintanguy I. Complicações tardias dos preenchimentos permanentes. Rev Bras Cir Plást, v. 24, n. 1, p. 71-81, 2009.

Perez-pérez L, García GJ, Wortsman X, Santos BA. Delayed adverse subcutaneous reaction to a new family of hyaluronic acid dermal fillers with clinical, ultrasound, and histologic correlation. Dermatol Surg. 2017;43(4):605-8.

Signorini M, et al. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers: evidence, and opinion, based review and consensus recommendations – Plast Reconstr Surg. 2016; 137 (6): 961-71.

Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed-onset nodules secondary to a smooth cohesive 20 mg/ml hyaluronic acid filler: cause and management. Dermatol Surg. 2015; 41(8):929-39.

Bhojani-Lynch T. Late-onset inflammatory response to hyaluronic acid dermal fillers. Plastic and Reconstructive Surgery - Global Open, 2017. 5(12), 1–7.

Tosti R, Jennings J, Sewards JM. Lateral epicondylitis of the elbow. Am J Med. 2013; 126:1–6.

Almeida ART, Sampaio GAA. Ácido hialurônico no rejuvenescimento do terço superior da face: revisão e atualização - parte 1. Revista Surgical & Cosmetic Dermatology, Rio de Janeiro, v.8, n.2, p.148- 153, 2015.

Santana ING, Rostey RRL. Relato de Caso: edema tardio intermitente e persistente (etip) de implante de ácido hialurônico desencadeado pela covid-19. Surgical & Cosmetic Dermatology. v. 12, n. 4, p. 373-375: 2020.